DK154326C - Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning - Google Patents

Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning Download PDF

Info

Publication number
DK154326C
DK154326C DK396381A DK396381A DK154326C DK 154326 C DK154326 C DK 154326C DK 396381 A DK396381 A DK 396381A DK 396381 A DK396381 A DK 396381A DK 154326 C DK154326 C DK 154326C
Authority
DK
Denmark
Prior art keywords
nifedipine
preparations
preparation
long
specific surface
Prior art date
Application number
DK396381A
Other languages
Danish (da)
English (en)
Other versions
DK154326B (da
DK396381A (da
Inventor
Ahmed Hegasy
Klaus-Dieter Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6111496&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK154326(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of DK396381A publication Critical patent/DK396381A/da
Publication of DK154326B publication Critical patent/DK154326B/da
Application granted granted Critical
Publication of DK154326C publication Critical patent/DK154326C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
DK396381A 1980-09-09 1981-09-08 Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning DK154326C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3033919 1980-09-09
DE19803033919 DE3033919A1 (de) 1980-09-09 1980-09-09 Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung

Publications (3)

Publication Number Publication Date
DK396381A DK396381A (da) 1982-03-10
DK154326B DK154326B (da) 1988-11-07
DK154326C true DK154326C (da) 1995-03-13

Family

ID=6111496

Family Applications (1)

Application Number Title Priority Date Filing Date
DK396381A DK154326C (da) 1980-09-09 1981-09-08 Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning

Country Status (20)

Country Link
EP (1) EP0047899B2 (2)
JP (1) JPS5914446B2 (2)
AR (1) AR226377A1 (2)
AT (1) ATE5761T1 (2)
AU (1) AU558331B2 (2)
CA (1) CA1180277A (2)
DD (1) DD201974A5 (2)
DE (2) DE3033919A1 (2)
DK (1) DK154326C (2)
FI (1) FI72648B (2)
GR (1) GR78237B (2)
HU (1) HU184879B (2)
IE (1) IE51549B1 (2)
IL (1) IL63749A (2)
NO (1) NO157368B (2)
NZ (1) NZ198285A (2)
PH (1) PH24097A (2)
PL (1) PL232951A1 (2)
PT (1) PT73603B (2)
ZA (1) ZA816213B (2)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264446A (en) * 1980-09-09 1993-11-23 Bayer Aktiengesellschaft Solid medicament formulations containing nifedipine, and processes for their preparation
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3222367A1 (de) * 1982-06-15 1983-12-15 Bayer Ag, 5090 Leverkusen Verwendung von 1,4-dihydropyridinen in antiarteriosklerotika und deren herstellung
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4529733A (en) * 1983-04-06 1985-07-16 Merrell Dow Pharmaceuticals Inc. Antihypertensive 3-furoyl-1,4-dihydropyridines
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
NL194389C (nl) * 1984-06-14 2002-03-04 Novartis Ag Werkwijze voor het bereiden van een vaste dispersie van een farmaceutisch actief middel dat een lage oplosbaarheid in water heeft, in een vaste matrix van een in water oplosbaar polyalkyleenglycol als drager.
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4940556A (en) * 1986-01-30 1990-07-10 Syntex (U.S.A.) Inc. Method of preparing long acting formulation
US5198226A (en) * 1986-01-30 1993-03-30 Syntex (U.S.A.) Inc. Long acting nicardipine hydrochloride formulation
CH673947A5 (2) * 1986-09-23 1990-04-30 Sandoz Ag
JPS6464659A (en) * 1987-09-03 1989-03-10 Kenbi Kogaku Kenkyusho Kk Preparation of safe and effective powder formulation
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3814532A1 (de) * 1988-04-29 1989-11-09 Bayer Ag Dhp-retard-zubereitung
JPH0298550U (2) * 1989-01-25 1990-08-06
GB8903328D0 (en) * 1989-02-14 1989-04-05 Ethical Pharma Ltd Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
DE4130173A1 (de) * 1991-09-11 1993-03-18 Bayer Ag Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
US5543099A (en) * 1994-09-29 1996-08-06 Hallmark Pharmaceutical, Inc. Process to manufacture micronized nifedipine granules for sustained release medicaments
ES2168351T3 (es) * 1994-12-29 2002-06-16 Shire Deutschland Gmbh & Co Kg Preparaciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion.
JP3220373B2 (ja) 1995-11-28 2001-10-22 バイエル薬品株式会社 持続性ニフエジピン製剤
IL123505A (en) 1996-07-08 2004-12-15 Penwest Pharmaceuticals Compan Sustained release matrix for high-dose insoluble drugs
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
ES2304980T3 (es) 1999-09-30 2008-11-01 Penwest Pharmaceuticals Co. Sistemas de matriz de liberacion sostenida para farmacos altamente solubles.
CN101862322A (zh) 2004-07-30 2010-10-20 托伦特药物有限公司 奈必洛尔及其药学可接受盐、制备方法以及奈必洛尔的药物组合物
DE102004062475A1 (de) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Feste, oral applizierbare pharmazeutische Darreichungsformen mit modifizierter Freisetzung

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3330727A (en) * 1960-04-19 1967-07-11 Glaxo Lab Ltd Griseofulvin with high specific surface area
US3401221A (en) * 1964-08-25 1968-09-10 Norwich Pharma Co Treatment of urinary tract infection
DE2348334C2 (de) * 1973-09-26 1982-11-11 Boehringer Mannheim Gmbh, 6800 Mannheim Neue Zubereitungsform des N-4-[2-(5-Chlor-2-methoxybenzamido)äthyl]- phenyl-sulfonyl-N'-cyclohexylharnstoffs
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
JPS55129221A (en) * 1979-03-29 1980-10-06 Kaken Pharmaceut Co Ltd Preparation of oral preparation containing hardly soluble medicine
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material

Also Published As

Publication number Publication date
CA1180277A (en) 1985-01-02
FI812758L (fi) 1982-03-10
PT73603B (en) 1982-11-10
GR78237B (2) 1984-09-26
IL63749A (en) 1984-06-29
NO157368B (no) 1987-11-30
EP0047899B1 (de) 1984-01-04
DE3033919A1 (de) 1982-04-22
EP0047899A1 (de) 1982-03-24
FI72648B (fi) 1987-03-31
NO812879L (no) 1982-03-10
DD201974A5 (de) 1983-08-24
NZ198285A (en) 1984-04-27
AU558331B2 (en) 1987-01-29
JPS5750913A (en) 1982-03-25
PL232951A1 (2) 1982-10-11
ATE5761T1 (de) 1984-01-15
DK154326B (da) 1988-11-07
IE812075L (en) 1982-03-09
HU184879B (en) 1984-10-29
JPS5914446B2 (ja) 1984-04-04
ZA816213B (en) 1982-09-29
DE3161838D1 (en) 1984-02-09
IL63749A0 (en) 1981-12-31
IE51549B1 (en) 1987-01-07
DK396381A (da) 1982-03-10
AU7506381A (en) 1982-03-18
PT73603A (en) 1981-09-01
AR226377A1 (es) 1982-06-30
EP0047899B2 (de) 1996-02-28
PH24097A (en) 1990-03-05

Similar Documents

Publication Publication Date Title
DK154326C (da) Fremgangsmåde til fremstilling af faste Nifedipin--præparater med langvaring virkning
US5264446A (en) Solid medicament formulations containing nifedipine, and processes for their preparation
DK163278B (da) Fast tofaselaegemiddelpraeparat indeholdende nifedipin og fremgangsmaade til fremstilling deraf
KR0183027B1 (ko) 류코트리엔의 작용에 대한 길항작용이 요구되는 질환의 치료용 약학 조성물 및 이의 제조 방법
AU2002222567B2 (en) Composition improved in solubility or oral absorbability
BE1014449A6 (nl) Farmaceutische verbindingen omvattende amlodipine maleaat.
CA1146866A (en) Process for the production of sustained release pharmaceutical composition of solid medical material
FI119722B (fi) Valasikloviiritabletteja, jotka sisältävät kolloidista silikonidioksidia
GB1579818A (en) Nifedipine-containing solid preparation composition
KR20020082230A (ko) 저용량의 엔테카비르 제제 및 그의 용도
EA022950B1 (ru) Применение частиц носителя диоксида кремния для улучшения технологических характеристик фармацевтического агента
NO329943B1 (no) Stabiliserte, farmasoytiske preparater inneholdende azelnidipin som kalsiumkanalblokker
CN113041244B (zh) 含苯磺酸左氨氯地平水合物的组合物及其制备方法
EP0310999B1 (en) Pharmaceutical composition for piperidinoalkanol derivatives
IE921864A1 (en) Micropellets and a process for their manufacture
CN115124420B (zh) 大黄酸与苦参碱共晶物水合物及制备方法和其组合物与用途
NO313404B1 (no) Farmasöytisk preparat omfattende paroksetin, fremgangsmåte for fremstilling av preparatet, samt anvendelse derav
JPH0737383B2 (ja) 胃酸分泌抑制剤含有固型製剤
JPH032183A (ja) ビスベンジルイソキノリン誘導体
JPH09309829A (ja) ニトレンジピン含有経口投与製剤およびその製造法
JPH0632737A (ja) 徐放性ニフェジピン製剤及びその製造方法
JPH0413629A (ja) 新規な大腸過敏症治療剤
JPH0672870A (ja) 抗潰瘍剤
JPH0368557A (ja) ビスべンジルイソキノリン誘導体
HK1019003B (en) Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole(pramipexol) as an anti-depressant drug

Legal Events

Date Code Title Description
PUP Patent expired